SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
Using neutral language with patients and thorough documentation can help mitigate your practice’s legal risks when utilizing ...
SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
Children with nontraumatic cataracts undergoing implantation of a secondary intraocular lens (IOL) after lensectomy are at a risk for complications including a diagnosis of glaucoma and visual axis ...
Please provide your email address to receive an email when new articles are posted on . Age-related dementia, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy and hearing ...
Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...
Did you know that when your ASC facility has a Medicare patient who requests a Presbyopia-Correcting (PC) IOL lens or an Astigmatism-Correcting (AC) IOL lens (instead of a regular IOL) that there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results